AR061355A1 - Preparaciones de combinacion que comprenden slv308 y l-dopa - Google Patents
Preparaciones de combinacion que comprenden slv308 y l-dopaInfo
- Publication number
- AR061355A1 AR061355A1 ARP070102580A ARP070102580A AR061355A1 AR 061355 A1 AR061355 A1 AR 061355A1 AR P070102580 A ARP070102580 A AR P070102580A AR P070102580 A ARP070102580 A AR P070102580A AR 061355 A1 AR061355 A1 AR 061355A1
- Authority
- AR
- Argentina
- Prior art keywords
- slv308
- dopa
- treatment
- pharmaceutically acceptable
- amount
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 5
- YVPUUUDAZYFFQT-UHFFFAOYSA-N 7-(4-methylpiperazin-1-yl)-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C1=CC=CC2=C1OC(=O)N2 YVPUUUDAZYFFQT-UHFFFAOYSA-N 0.000 title abstract 3
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 title abstract 3
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 title abstract 3
- 150000001204 N-oxides Chemical class 0.000 abstract 2
- 208000018737 Parkinson disease Diseases 0.000 abstract 2
- 208000005793 Restless legs syndrome Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 229940123736 Decarboxylase inhibitor Drugs 0.000 abstract 1
- 102000010909 Monoamine Oxidase Human genes 0.000 abstract 1
- 108010062431 Monoamine oxidase Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003954 decarboxylase inhibitor Substances 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000010249 dopaminergic function Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06115583 | 2006-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR061355A1 true AR061355A1 (es) | 2008-08-20 |
Family
ID=37513845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070102580A AR061355A1 (es) | 2006-06-16 | 2007-06-13 | Preparaciones de combinacion que comprenden slv308 y l-dopa |
Country Status (7)
| Country | Link |
|---|---|
| CN (1) | CN101516371A (zh) |
| AR (1) | AR061355A1 (zh) |
| BR (1) | BRPI0713695A2 (zh) |
| MX (1) | MX2008016225A (zh) |
| SA (1) | SA07280317B1 (zh) |
| TW (1) | TW200813038A (zh) |
| UA (1) | UA94466C2 (zh) |
-
2007
- 2007-06-13 AR ARP070102580A patent/AR061355A1/es not_active Application Discontinuation
- 2007-06-13 TW TW096121305A patent/TW200813038A/zh unknown
- 2007-06-13 SA SA7280317A patent/SA07280317B1/ar unknown
- 2007-06-15 UA UAA200900253A patent/UA94466C2/ru unknown
- 2007-06-15 BR BRPI0713695-1A patent/BRPI0713695A2/pt not_active IP Right Cessation
- 2007-06-15 CN CNA2007800225200A patent/CN101516371A/zh active Pending
- 2007-06-15 MX MX2008016225A patent/MX2008016225A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0713695A2 (pt) | 2012-10-30 |
| CN101516371A (zh) | 2009-08-26 |
| MX2008016225A (es) | 2009-01-19 |
| SA07280317B1 (ar) | 2010-09-29 |
| TW200813038A (en) | 2008-03-16 |
| UA94466C2 (ru) | 2011-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20160195A1 (es) | Uso de pridopidina en dosis altas para el tratamiento de enfermedad de huntington | |
| CO6470887A2 (es) | Derivados de 1h-imidazo-[4,5-c]-quinolinona. | |
| NO20075136L (no) | Nye liposompreparater | |
| AR075735A1 (es) | Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso | |
| CO6331425A2 (es) | Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida | |
| BRPI0416796A (pt) | compostos orgánicos | |
| BRPI0508540A8 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| CL2007001918A1 (es) | Compuestos derivados heteroarilos sustituidos; metodo para la preparacion de los compuestos; composicion farmaceutica; y uso para el tratamiento del dolor, depresion, enfermedad de alzheimer e hipertension entre otras. | |
| NI201100147A (es) | Métodos para tratar infartos agudos de miocardio y trastornos relacionados. | |
| CL2009002183A1 (es) | Uso de una composicion topica que comprende 2.5% de imiquimod y un vehiculo farmaceuticamente aceptable para preparar un medicamento util para tratar queratosisi actinica; composicion topica. | |
| UY32691A (es) | Compuestos de 1h-imidazo-[4,5-c]-quinolinona | |
| CL2011001927A1 (es) | Uso de una composicion farmaceutica de liberacion sostenida, que comprende como ingrediente activo a 4-aminopiridina, que sirve para preparar un medicamento util para el tratamiento de la esclerosis multiple, en dos dosis de 10 miligramos diarias, que permite recuperar la marcha de un paciente afectado. | |
| AR039164A1 (es) | Sales de venlafaxina de baja solubilidad en agua | |
| CY1114163T1 (el) | Μεθοδοι χρησεως ανταγωνιστων αγγειοπιεσινης με παραγοντες χημειοθεραπειας ανθρακυκλινης για να μειωνεται καρδιοτοξικοτητα ή/και να βελτιωνεται επιβιωση | |
| AR045783A1 (es) | Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide | |
| WO2004100893A3 (en) | Methods for treatment of inflammatory diseases using ct-3 or analogs thereof | |
| ECSP078014A (es) | Regimen de dosificacion para prasugrel | |
| AR080096A1 (es) | Tratamiento combinado de cancer de pancreas con gemcitabina y masitinib | |
| DOP2005000051A (es) | Oxadiazolonas, procedimientos para su preparacion y su uso como productos farmaceuticos | |
| AR064543A1 (es) | Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales | |
| MX341660B (es) | Agonista del receptor de ghrelina para el tratamiento de caquexia. | |
| BR112015012497A8 (pt) | combinações e composições farmacêuticas, seus usos, preparação combinada, e embalagem comercial | |
| ECSP077843A (es) | Tratamiento o prevención del prurito | |
| EA200970022A1 (ru) | Комбинированные препараты, содержащие бифепрунокс и l-допу | |
| AR048318A1 (es) | Formulaciones de matriz orales que comprenden licarbazepina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |